What we do
GeoFront Capital is a leading Market Research firm providing timely actionable research analysis within a global context. Our research is comprehensive, detailed, and thoroughly reviewed. We concentrate and specialize in research regarding technology, healthcare, commercial aviation, commodities, and defense.
Subscribe to our market updates to find unique investment perspectives and our industry analysis on where the markets are headed. We issue general market reviews along with a quarterly publication with actionable investment advice and projections. Download our sample newsletter today or sign up for a trial subscription to see how our research can benefit your institution, hedge fund, or for your own personal investment goals.
Use us as a source for unbiased analysis on current events and trends, and how they will affect the markets. We provide commentary on major technical and fundamental events through the lense of the financial markets. We also periodically review literature and research we find beneficial and interesting in our own market reviews.
GFC has a large library of Market Research we compile during our overall market analysis which covers multiple sectors in the market. Use this research to augment your investment analysis, and provide a highly researched perspective on multiple financial topics.
Let us partner with your organization to provide the analysis and insight you’re looking for. We provide services ranging from custom research to more hands-on needs, providing the insight and delivering the intelligence you need. Contact us and we will work with your organization to tailor a solution to fit your research needs.
GeoFront Capital has developed a series of proprietary indices to track and trend unique technical measures. These cover a wide range of data sets giving you insight into areas of the market previously not visible. Data is accessible via standardized data feeds and JSON API integration.
Slumps from gold miners to REITs to utilities suggest a risk of rate hikes that Treasuries have dismissed.Aug23
The medical instrument maker should get a big lift from a test that detects heart attacks in ER patients.Aug23
Shares of Trinity Biotech could get a big lift from a test that can detect heart attacks in ER patients.